يعرض 161 - 180 نتائج من 12,855 نتيجة بحث عن '(( significant classes based ) OR ( significantly ((smaller decrease) OR (small decrease)) ))', وقت الاستعلام: 0.72s تنقيح النتائج
  1. 161
  2. 162
  3. 163

    Swell dataset (multi-class, 3 classes). حسب Mashael M. Khayyat (20442292)

    منشور في 2024
    "…In this paper, we propose a new approach based on the CapsNets model for continuously monitoring psychophysiological stress. …"
  4. 164
  5. 165
  6. 166
  7. 167
  8. 168
  9. 169
  10. 170

    Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung C... حسب Kuojun Zhang (10339222)

    منشور في 2022
    "…Inspired by the synergistic antitumor effect between NAD­(P)­H:quinone oxidoreductase 1 (NQO1) substrates increasing the NAD consumption and nicotinamide phosphoribosyltransferase (NAMPT) inhibitors hampering the NAD synthesis, first-in-class small molecules simultaneously targeting NQO1 and NAMPT were identified through structure-based design. …"
  11. 171

    Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung C... حسب Kuojun Zhang (10339222)

    منشور في 2022
    "…Inspired by the synergistic antitumor effect between NAD­(P)­H:quinone oxidoreductase 1 (NQO1) substrates increasing the NAD consumption and nicotinamide phosphoribosyltransferase (NAMPT) inhibitors hampering the NAD synthesis, first-in-class small molecules simultaneously targeting NQO1 and NAMPT were identified through structure-based design. …"
  12. 172

    Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung C... حسب Kuojun Zhang (10339222)

    منشور في 2022
    "…Inspired by the synergistic antitumor effect between NAD­(P)­H:quinone oxidoreductase 1 (NQO1) substrates increasing the NAD consumption and nicotinamide phosphoribosyltransferase (NAMPT) inhibitors hampering the NAD synthesis, first-in-class small molecules simultaneously targeting NQO1 and NAMPT were identified through structure-based design. …"
  13. 173
  14. 174
  15. 175
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180